[PubMed Citation] Fujita Y, Fujino Y, Onodera M, Kikuchi S, Kikkawa T, Inoue Y, Niitsu H, Takahashi K, Endo S
Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
In addition, only trials reporting thyroid events were included in this analysis, leading to an unclear risk of reporting bias
La formulazione migliorata del 2025 Nel 2025 Novo Nordisk ha introdotto una nuova formulazione di Rybelsus, denominata tecnicamente R2, con eccipienti modificati che raddoppiano la biodisponibilit dallintervallo 0,41% della formulazione originale all12% della nuova (FDA, 2025)
So those are the two that I see that are pretty dramatic, where something else could have been worked up first
Kang B, Kim Y, Park TJ, Kang HY